MOLECULAR MECHANISMS OF V-ATPASES: ASSEMBLY, BIOGENESIS, REGULATION, AND FUNCTION
V-ATP酶的分子机制:组装、生物发生、调节和功能
基本信息
- 批准号:10664015
- 负责人:
- 金额:$ 39.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:ATP phosphohydrolaseAcquired Immunodeficiency SyndromeAddressAdenosineBiochemicalBiogenesisBiological AssayBiophysicsCellsComplementComplexCryoelectron MicroscopyDiabetes MellitusDiseaseEmbryoEndosomesEukaryotic CellGlycolipidsGolgi ApparatusHumanInfectionLipidsLysosomesMalignant NeoplasmsMammalsMass Spectrum AnalysisMediatingMembraneMethodsModelingMolecularNeurodegenerative DisordersOrganellesOrganismOsteoporosisPhysiological ProcessesPlayPolysaccharidesProteinsProton PumpProtonsRegulationRenal tubular acidosisResolutionRoleSensorineural Hearing LossSignal TransductionStructureVesicleWorkexperimental studyextracellularhuman diseaseinnovationinsightmicrobialnovel therapeutic interventionpH Homeostasisvacuolar H+-ATPaseyeast genetics
项目摘要
Summary
Vesicular- or vacuolar-type adenosine triphosphatases (V-ATPases) are multi-component, ATP-driven proton
pumps consisting of a V1 complex that possesses ATPase activity and a Vo complex for proton transfer across
the membrane. V-ATPases play important roles in the acidification of intracellular vesicles, organelles, and the
extracellular milieu, and are essential for maintaining the pH homeostasis of endosomes, lysosomes, and the
Golgi apparatus in all eukaryotic cells. V-ATPase deficiency in mammals is embryonic lethal, and malfunction of
V-ATPases is associated with numerous diseases, including microbial infection, renal tubular acidosis,
osteoporosis, sensorineural deafness, neurodegenerative diseases, and cancer. Despite the critical functions of
V-ATPases, we have limited understanding on the biogenesis, assembly, regulation, and signaling of mammalian
V-ATPases. A major challenge in studying mammalian V-ATPases is that the pure complexes are difficult to
obtain for biochemical and biophysical experiments. We developed an innovative method to purify large amounts
of human V-ATPase to homogeneity directly from cells. Our preliminary cryo-electron microscopy (cryo-EM)
structures of human V-ATPases show three functional states at up to 3.1 Å resolution and with all known subunits,
which together represent the most complete mechanistic model of V-ATPase to date. Our study revealed that
mammalian V-ATPases are composed of proteins, glycans, glycolipids, and lipids. Therefore, we defined the V-
ATPase as a glycoproteolipid complex. Our study opened up the field for comprehensively understanding the
biogenesis, assembly, regulation, and signaling of V-ATPases. Based on our prior work, we will complement
cryo-EM structure determination with biochemical and functional assays, yeast genetics, and mass spectrometry
analysis to address fundamental questions in the field, including the roles of glycolipids in the V-ATPase
assembly and function, the regulation of V-ATPases by reversible assembly, the detailed mechanism of proton
transfer, and the mechanisms of V-ATPase mediated cell signaling. The completion of this project will not only
provide conceptual innovations regarding the V-ATPases assembly, regulation, and signaling, but also inspire
new therapeutic strategies for treating V-ATPase-related diseases.
总结
囊泡型或空泡型腺苷三磷酸酶(V-ATP酶)是一种多组分、ATP驱动的质子酶
由具有ATP酶活性的V1复合物和用于质子转移的Vo复合物组成的泵
膜。V-ATP酶在细胞内囊泡、细胞器和细胞外基质的酸化中起重要作用。
细胞外环境,并为维持内体,溶酶体和细胞外环境的pH稳态所必需。
所有真核细胞中的高尔基体。哺乳动物的V-ATP酶缺乏是胚胎致死性的,
V-ATP酶与许多疾病有关,包括微生物感染、肾小管酸中毒、
骨质疏松症、感觉神经性耳聋、神经变性疾病和癌症。尽管有关键的功能,
V-ATP酶,我们对哺乳动物细胞的生物发生、组装、调节和信号传导的了解有限,
V-ATP酶研究哺乳动物V-ATP酶的一个主要挑战是,纯复合物很难被纯化。
用于生物化学和生物物理实验。我们发明了一种新方法
将人V-ATP酶直接从细胞中纯化至均一。我们初步的冷冻电镜(cryo-EM)
人V-ATP酶的结构在高达3.1 μ m的分辨率下显示出三种功能状态并且具有所有已知的亚基,
它们共同代表了迄今为止V-ATP酶的最完整的机理模型。我们的研究显示,
哺乳动物V-ATP酶由蛋白质、聚糖、糖脂和脂质组成。因此,我们定义了V-
ATP酶作为糖蛋白脂质复合物。我们的研究为全面了解
V-ATP酶的生物发生、组装、调节和信号传导。基于我们之前的工作,我们将补充
cryo-EM结构测定与生化和功能测定、酵母遗传学和质谱分析
分析以解决该领域的基本问题,包括糖脂在V-ATPase中的作用
组装和功能,可逆组装对V-ATP酶的调节,质子的详细机制
以及V-ATP酶介导的细胞信号转导机制。该项目的完成不仅将
提供有关V-ATP酶组装,调节和信号传导的概念创新,但也启发了
治疗V-ATP酶相关疾病的新治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tianmin Fu其他文献
Tianmin Fu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tianmin Fu', 18)}}的其他基金
MOLECULAR MECHANISMS OF V-ATPASES: ASSEMBLY, BIOGENESIS, REGULATION, AND FUNCTION
V-ATP酶的分子机制:组装、生物发生、调节和功能
- 批准号:
10501202 - 财政年份:2022
- 资助金额:
$ 39.38万 - 项目类别:
Molecular Mechanisms Of V-ATPases: Assembly,Biogenesis, Regulation, And Function
V-ATP 酶的分子机制:组装、生物发生、调节和功能
- 批准号:
10798892 - 财政年份:2022
- 资助金额:
$ 39.38万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 39.38万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 39.38万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 39.38万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 39.38万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 39.38万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 39.38万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 39.38万 - 项目类别:














{{item.name}}会员




